A novel adjuvant-free H fusion system for the production of recombinant immunogens in Escherichia coli: Its application to a 12 kDa antigen from Cryptosporidium parvum

Bioengineered

Volumn 4, Issue 6, 2013, Pages 413-419

  Costa, Sofia J ^a,b   Silva, Pedro ^b,c   Almeida, André ^d,e   Conceição, Antónia ^c   Domingues, Lucília ^a   Castro, António ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c INSTITUTO POLITÉCNICO DE COIMBRA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e Biocant Parque Tecnológico de cantanhede   (Portugal)

Author keywords

Antibody production; CP12; Cryptosporidium; Free adjuvant immunization; Immunogens; Novel fusion partner

Indexed keywords

CP12 ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENE FUSION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MOUSE; NONHUMAN; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; BLOOD; CP12; CRYPTOSPORIDIUM; FREE-ADJUVANT IMMUNIZATION; GENETICS; IMMUNOGENS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NOVEL FUSION PARTNER; NUCLEOTIDE SEQUENCE; OOCYST;

ANIMALIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; ESCHERICHIA COLI;

ANTIBODY PRODUCTION; CP12; CRYPTOSPORIDIUM; FREE-ADJUVANT IMMUNIZATION; IMMUNOGENS; NOVEL FUSION PARTNER;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CRYPTOSPORIDIUM PARVUM; DNA, PROTOZOAN; ESCHERICHIA COLI; GENE FUSION; MICE; MOLECULAR SEQUENCE DATA; OOCYSTS; RECOMBINANT PROTEINS;

EID: 85052275091     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bioe.26003     Document Type: Article

References (28)

1. Chowdhury PS, Gallo M, Pastan I. Generation of high titer antisera in rabbits by DNA immunization. J Immunol Methods 2001; 249:147-154; PMID:11226472; http://dx.doi.org/10.1016/S0022-1759(00)00353-7
2. Löwenadler B, Nilsson B, Abrahmsén L, Moks T, Ljungqvist L, Holmgren E, Paleus S, Josephson S, Philipson L, Uhlén M. Production of specific antibodies against protein A fusion proteins. EMBO J 1986; 5:2393-2398; PMID:3096719
3. Demain AL, Vaishnav P. Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 2009; 27:297-306; PMID:19500547; http://dx.doi.org/10.1016/j.biotechadv.2009.01.008
4. Jana S, Deb JK. Strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol 2005; 67:289-298; PMID:15635462; http://dx.doi.org/10.1007/s00253-004-1814-0
5. Peti W, Page R. Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. Protein Expr Purif 2007; 51:1-10; PMID:16904906; http://dx.doi.org/10.1016/j.pep.2006.06.024
6. Sørensen H P, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005; 4:1; PMID:15629064; http://dx.doi.org/10.1186/1475-2859-4-1
7. Sørensen H P, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 2005; 115:113-128; PMID:15607230; http://dx.doi.org/10.1016/j.jbiotec.2004.08.004
8. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2006; 72:211-222; PMID:16791589; http://dx.doi.org/10.1007/s00253-006-0465-8
9. Vallejo L F, Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 2004; 3:11; PMID:15345063; http://dx.doi.org/10.1186/1475-2859-3-11
10. Villaverde A, Carrió MM. Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol Lett 2003; 25:1385-1395; PMID:14514038; http://dx.doi.org/10.1023/A:1025024104862
11. Esposito D, Chatterjee DK. Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 2006; 17:353-358; PMID:16781139; http://dx.doi.org/10.1016/j.copbio.2006.06.003
12. Nilsson J, Ståhl S, Lundeberg J, Uhlén M, Nygren PA. Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins. Protein Expr Purif 1997; 11:1-16; PMID:9325133; http://dx.doi.org/10.1006/prep.1997.0767
13. Waugh DS. Making the most of affinity tags. Trends Biotechnol 2005; 23:316-320; PMID:15922084; http://dx.doi.org/10.1016/j.tibtech.2005.03.012
14. Young CL, Britton ZT, Robinson AS. Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications. Biotechnol J 2012; 7:620-634; PMID:22442034; http://dx.doi.org/10.1002/biot.201100155
15. Chuang CK, Su YS, Fan CT, Lee WC, Chen MY. A dual-functional E. coli vector for expressing recom-binant protein with high solubility and antigen presentation ability. Protein Expr Purif 2009; 65:51-56; PMID:19162194; http://dx.doi.org/10.1016/j. pep.2008.12.011
16. Kaslow DC, Shiloach J. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. Biotechnology (N Y) 1994; 12:494-499; PMID:7764708; http://dx.doi.org/10.1038/nbt0594-494
17. Kink JA, Williams JA. Antibodies to recombinant Clostridium difficult toxins A and B are an effective treatment and prevent relapse of C. difficult-associated disease in a hamster model of infection. Infect Immun 1998; 66:2018-2025; PMID:9573084
18. Sjölander A, Nygren PA, Stahl S, Berzins K, Uhlen M, Perlmann P, Andersson R. The serum albumin-binding region of streptococcal protein G: a bacterial fusion partner with carrier-related properties. J Immunol Methods 1997; 201:115-123; PMID:9032414; http://dx.doi.org/10.1016/S0022-1759(96)00217-7
19. López-Monteon A, Ramos-Ligonio A, Pérez-Castillo L, Talamás-Rohana P, Rosales-Encina JL. Specific antibody immune response against the parasitic portion of a glutathione-S-transferase fusion protein. FASEB J 2003; 17:621-627; PMID:12665474; http://dx.doi.org/10.1096/fj.02-0471com
20. Barrell PJ, Liew OW, Conner AJ. Expressing an antibacterial protein in bacteria for raising antibodies. Protein Expr Purif 2004; 33:153-159; PMID:14680972; http://dx.doi.org/10.1016/j.pep.2003.08.026
21. Knuth MW, Okragly AJ, Lesley SA, Haak-Frendscho M. Facile generation and use of immunogenic poly-peptide fusions to a sparingly soluble non-antigenic protein carrier. J Immunol Methods 2000; 236:53-69; PMID:10699579; http://dx.doi.org/10.1016/S0022-1759(99)00230-6
22. Andersson C, Sandberg L, Wernérus H, Johansson M, Lövgren-Bengtsson K, Ståhl S. Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation. J Immunol Methods 2000; 238:181-193; PMID:10758248; http://dx.doi.org/10.1016/S0022-1759(00)00146-0
23. Silva ECA, Castro A, Lopes A, Rodrigues A, Dias C, Conceição A, Alonso J, Correia da Costa JM, Bastos M, Parra F, et al. A recombinant antigen recognized by Fasciola hepatica-infected hosts. J Parasitol 2004; 90:746-751; PMID:15357063; http://dx.doi.org/10.1645/GE-136R
24. Costa SJ, Almeida A, Castro A, Domingues L, Besir H. The novel Fh8 and H fusion partners for soluble protein expression in Escherichia coli: a comparison with the traditional gene fusion technology. Appl Microbiol Biotechnol 2013; 97:6779-6779; PMID:23160981
25. Yao L, Yin J, Zhang X, Liu Q, Li J, Chen L, Zhao Y, Gong P, Liu C. Cryptosporidium parvum: identification of a new surface adhesion protein on sporozoite and oocyst by screening of a phage-display cDNA library. Exp Parasitol 2007; 115:333-338; PMID:17097085; http://dx.doi.org/10.1016/j.exppara.2006.09.018
26. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B sub-unit as immunogen, carrier, and adjuvant. Am J Trop Med Hyg 1994; 50(Suppl):42-54; PMID:8203723
27. Liljeqvist S, Ståhl S, Andréoni C, Binz H, Uhlén M, Murby M. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J Immunol Methods 1997; 210:125-135; PMID:9520296; http://dx.doi.org/10.1016/S0022-1759(97)00170-1
28. Arrowood MJ, Donaldson K. Improved purification methods for calf-derived Cryptosporidium par-vum oocysts using discontinuous sucrose and cesium chloride gradients. J Eukaryot Microbiol 1996; 43:89S; PMID:8822880; http://dx.doi.org/10.1111/j.1550-7408.1996.tb05015.x